Immunocore Holdings (6YG) Ownership - Who Owns Immunocore Holdings?
Immunocore Holdings (6YG) Ownership Overview
- 0.04% Insiders
- 22.83% Mutual Funds
- 0.27% Other Institutional Investors
- 1.50% ETFs
- 75.36% Public Companies and Individual Investors
The ownership structure of Immunocore Holdings (DE:6YG) stock is a mix of institutional, retail, and individual investors. Approximately 24.60% of the company’s stock is owned by Institutional Investors, 0.04% is owned by Insiders, and 75.36% is owned by Public Companies and Individual Investors.
The ownership structure of Immunocore Holdings (DE:6YG) stock is a mix of institutional, retail, and individual investors. Approximately 24.60% of the company’s stock is owned by Institutional Investors, 0.04% is owned by Insiders, and 75.36% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | €336,791 | |
| Dec 31, 2025 | Bridgewater Associates, Lp | €345,433 | |
| Dec 31, 2025 | Hussman Strategic Advisors Inc | €1,457,820 | |
| Dec 31, 2025 | Woodline Partners Lp | €10,992,136 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Specialized Funds | 4,246,274 | Institution | 8.25% | 126,568,689 |
| Theofanis Kolokotrones | 3,638,241 | Institution | 7.06% | 108,445,049 |
| Vanguard Horizon Funds | 2,335,650 | Institution | 4.54% | 69,618,720 |
| Primecap Odyssey Funds | 1,111,200 | Institution | 2.16% | 33,121,538 |
| Fidelity Mt. Vernon Street Trust | 942,490 | Institution | 1.83% | 28,092,799 |
| Fidelity Select Portfolios | 787,200 | Institution | 1.53% | 23,464,070 |
| Felix Baker | 734,397 | Institution | 1.43% | 21,890,171 |
| T. Rowe Price Health Sciences Fund, Inc. | 645,268 | Institution | 1.25% | 19,233,503 |
| Ishares | 451,274 | Institution | 0.88% | 13,451,124 |
| Michael Rockefeller | 316,762 | Institution | 0.62% | 9,441,725 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Specialized Funds | 4,246,274 | Institution | 8.25% | 126,568,689 |
| Vanguard Horizon Funds | 2,335,650 | Institution | 4.54% | 69,618,720 |
| Primecap Odyssey Funds | 1,111,200 | Institution | 2.16% | 33,121,538 |
| Fidelity Mt. Vernon Street Trust | 942,490 | Institution | 1.83% | 28,092,799 |
| Fidelity Select Portfolios | 787,200 | Institution | 1.53% | 23,464,070 |
| T. Rowe Price Health Sciences Fund, Inc. | 645,268 | Institution | 1.25% | 19,233,503 |
| Mfs Series Trust I | 304,295 | Institution | 0.59% | 9,070,121 |
| Fidelity Advisor Series Vii | 260,000 | Institution | 0.50% | 7,749,820 |
| Principal Funds, Inc | 217,900 | Institution | 0.42% | 6,494,945 |
| Blackrock Funds | 188,691 | Institution | 0.37% | 5,624,313 |
FAQ
Who Owns Immunocore Holdings (DE:6YG)?
According to the latest TipRanks data, approximately 24.60% of the company's stock is held by institutional investors, 0.04% is held by insiders, and 75.36% is held by public companies and individual investors.
What percentage of Immunocore Holdings (DE:6YG) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.60% of Immunocore Holdings (DE:6YG) stock is held by institutional investors: 22.83% by mutual funds, 1.50% by ETFs and 0.27% by other institutional investors.
What percentage of Immunocore Holdings (DE:6YG) stock is held by retail investors?
According to the latest TipRanks data, approximately 75.36% of Immunocore Holdings (DE:6YG) stock is held by public companies and individual investors.
Who owns the most shares of Immunocore Holdings (DE:6YG)?
VANGUARD SPECIALIZED FUNDS owns the most shares of Immunocore Holdings (DE:6YG).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
